HomeAI · summaries
Storia in 11 fonti
Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?
The White House has denied that the application was filed on behalf of President Donald Trump.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
White House Denies Trump Was Given Exclusive Weight Loss Drug
A report from STAT News said Eli Lilly and the FDA gave a 79-year-old man exclusive access to the drug after a request for it was made in April.
- ·
newrepublic.com
Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient
Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.
- ·
White House Flips Out Over Report Trump May Be on Weight Loss Drug
A stunning report reveals the president may have gotten an early access to an obesity drug to treat major medical issues.
- ·
Remember That Time Trump Said He “Probably Should” Take Ozempic?
A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.
- ·
statnews.com
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use”…
- ·
medpagetoday.com
White House Denies Trump Got Unapproved Obesity Drug
Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension
- ·
arstechnica.com
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
Public notice of a single "compassionate use" case is odd in every way.
- ·
huffpost.com
It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?
Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."
- ·
gizmodo.com
Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?
The White House has denied that the application was filed on behalf of President Donald Trump.
- ·
independent.co.uk
White House denies Trump is the mystery patient who got early access to obesity drug
A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’
- ·
nymag.com
Did Trump Get Early Access to Eli Lilly’s New Weight-Loss Drug?
The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let’s examine the evidence.
- ·
Is Trump on an Experimental Weight Loss Drug? An Investigation.
The FDA gave one well-connected 79-year-old early access to Eli Lilly’s new drug. Its sure sounds like the president, but let’s examine the evidence.
- ·
White House denies Trump was mystery patient given early access to weight-loss drug
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that…
- ·
washingtonexaminer.com
White House denies report Trump got access to experimental weight loss drug
The White House denied that the single approval of Eli Lilly's highly-anticipated weight loss drug retatrutide was for Trump after a STAT report.
- ·
benzinga.com
White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The Presi
White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.
- ·
Democrats press White House on who got special access to Eli Lilly’s new obesity drug
The unusual access to an experimental drug has captured the attention of the American public as well.